SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000898430-00-000263
Filing Date
2000-02-04
Accepted
2000-02-04 00:00:00
Documents
7
Period of Report
2000-01-20
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 6128
2 PRESS RELEASE EX-99.1 4642
3 SETTLEMENT & MUTUAL RELEASE AGREEMENT EX-99.2 23212
4 TECHNOLOGY ASSIGNMENT AGREEMENT EX-99.3 29778
5 COMMON STOCK & WARRANT AGREEMENT EX-99.4 47491
6 WARRANT EX-99.5 26033
7 SPONSORED RESEARCH & LICENSE AGREEMENT EX-99.6 83056
  Complete submission text file 0000898430-00-000263.txt   222555
Mailing Address 9333 GENESEE AVENUE SUITE 200 SAN DIEGO CA 92121
Business Address 9333 GENESEE AVENUE SUITE 200 SAN DIEGO CA 92121 8585879333
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (Filer) CIK: 0000899394 (see all company filings)

IRS No.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24672 | Film No.: 523374
SIC: 2834 Pharmaceutical Preparations